Abstract
The transdermal medication conveyance is one of the promising course of medication conveyance framework, since it by passes the main pass digestion, keeps away from inactivation of medications by pH impacts and compounds present in GI plot, gives a nonstop method of organization at rates moving toward zero request like that given by an intravenous implantation, increment the half existence of the medication, the conveyance is painless, no hospitalization is required, and works on persistent consistence. A definitive target of present examination in light of the turn of events and portrayal of proniosome based transdermal gels of drug has a place with various classifications by using reasonable parts. This item will give unsurprising and expanded length of action, physical and compound soundness, adaptability, great bioavailability for ineffectively solvent medications, works on natural half-life, evades the variance in drug levels, keeps up with plasma grouping of medications and builds the patient consistence. Eventually the patient will give ideal treatment at lower cost. This transporter framework is having the colossal open door in the space of transdermal conveyance, beauty care products, nutraceuticals and so on.
Keywords: Proniosomes, transdermal drug delivery, slurry method, stability
Full text article
References
Bhargava T, Ramchandani U,Shrivastava SK, Dubey PK. Areview on current trends in NDDSwith special reference to NSAID’S.Int J Of Pharm And Bio Sci2011;21:92-114.
Mark R, Prausnitz, Langer R.Transdermal drug delivery. NatBiotechnol 2008;26(11): 1261–1268.
Radha GV, Sudha Rani T, SarvaniB. Proniosomal drug deliverysystem. J Of Basi And Clini Pharm2013;4:42-48.4.Sudhamani.T, Priyadarisini N,Radhakrishnan M. Proniosomes –promising drug carriers. Int JPharmTech Res 2010 ;2(2):1446-1454.
Pandey N. Proniosomes AndEthosomes: New prospect intransdermal and dermal drugdelivery system. IJPSR2011;2(8):1988-1996.
Rawat. Proniosome gel: a noveltopical delivery system. Int J OfRec Adv In Pharm Res 2011;3:1-10.
Sonam. Proniosomes: a recentadvancement in vesicular drugdelivery system. W J of Pharm Res2015; 4:1671-1689.
Kaur. A review on proniosome, apromising carrier for delivery ofdrug across membranes .W J OfPharm And Pharm Sci 2014;3:714-727.
Shehata. Proniosomal oral tabletsfor controlled delivery andenhanced pharmacokineticproperties of acemetacin. AAPSPharm Sci Tech 2011;16:375-383.
Vashist. Areview article proniosome.Pharma Tutor 2015:3;25-30.
Singh. Niosomal delivery ofisoniazid - development andcharacterization. Tro J Of PharmRes 2011;10 (2):203-210.
Lohumi. A novel drug deliverysystem: niosomes. Rev J Of DrugDeliv & Th 2012; 2(5):129-135.
Rekha.Formulation and characterisationof valsartan proniosomes. Maejo Int. J. Sci.Technol 2011;5(01):146-158.
Mehta M, Garg M. Proniosomalgel: a promising drug carrier forboswellic acids. J Med Sci 2015;15(3):130-134.
Bairwa NK, Choudhary D.Proniosome: a review. Asi J Of BioAnd Pharm Res 2011;2: 690-694.
Sadiq MD. Review on proniosome-a novel approach to vesicularsystem. Int J Of Nov Tre In PharmSci 2014;4:97-100.
Trupti, Udasi A. Proniosome: anovel approach to vesicular drugdelivery system. Int J Of PharmAnd Pharm Sci Res 2013;3(1):1-6.
Farooqui. A review on proniosomalgel: potential carrier system intransdermal delivery for non- steroidal anti-inflammatory Drugs(NSAID’s). Int J Of Pharm & LiSci 2014; 5(10):3939-3947.
Bharti. Proniosomes: a recentadvancement in nanotechnology asa drug carrier. Int J Of Pharm SciRev And Res 2012;12: 67-75.
Goudanavar. Development andcharacterization of perindoprilerbumine loaded proniosomal gel.Asian J Pharm Tech 2012;2:54-58.